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Humanfoamy virus (HFV) is a retrovirus encod-
ing structural genes and, like human immunode-
ficiency virus and human T ceU leukemia virus I, 
several anciUary reading frames collectively 
termed the belgenes. We have previously shown 
that HFV transgenic mice develop an encepha-
lopathy with neuronal loss in hippocampus and 
cerebral cortex. We have now raised and char-
acterized rabbit antisera to various recombinant 
portions of gag, pot, env, and bel-I, the viraltrans-
activator. Immunoreactivity for gag and bel-I was 
observed in nuclei and processes of hippocampal 
and cortical neurons before the onset of morpho-
logical lesions and correlated with the appear-
ance of HFV mRNA. Astrocyte-derived multinucle-
ated giant ceUs containing HFV proteins were 
present in the brain oftransgenic mice coexpress-
ingfuU-length HFV genes but not in mice express-
ing truncated gag and env, suggesting that these 
genes contain afusogenic domain. Expression of 
fuU-length structural genes decreased the life ex-
pectancy oftransgenic mice, implying an a4Juvant 
rolefor these proteins in HFV-induced brain dam-
age. (Am] Pathol 1993, 142:1061-1072) 
Human foamy virus (HFV) was originally isolated 20 
years ago from an African patient suffering from na-
sopharyngeal carcinoma. 1 Ever since the first HFV 
isolate was cloned and sequenced2 .3 characteriza-
tion of HFV has been rapidly progressing.4 --6 The ge-
nomic region between envand the 3' long terminal 
repeat bears particular interest since it encodes sev-
eral ancillary reading frames, including a retroviral 
trans-activator termed bel- t,7-9 
According to several serological surveys, HFV has 
attained a high prevalence in significant geographi-
cal areas, such as East Africa and the Pacific 
Islands, 10--12 and evidence for a role of HFV in specific 
pathologies is accumulating. For example, HFV has 
been isolated from patients with a variety of diseases, 
including, notably, encephalopathy (reviewed in ref. 
13). Nasopharyngeal carcinoma in Kenya and Tan-
zania is associated with an extraordinarily high prev-
alence of antibodies to HFV, and most intriguingly, 
seropositivity for HFV was recently reported to be very 
frequent in East African patients with acquired im-
mune deficiency syndrome and its related complex. 12 
Despite the increasing number of epidemiological 
clues pointing to pathogenic properties of HFV for 
humans and its prominent cytopathic effects in var-
ious types of cultured cells, 1.14 the pathogenic prop-
erties of HFV have thus far remained ill defined, and 
its potential threat to humans still awaits ultimate 
proof. In the present situation, characterized by an 
incomplete availability of epidemiological and molec-
ular data, in vivo model systems are proving invalu-
able to the study of the biology and pathogenic ef-
fects of HFV. We chose to study the biology of HFV in 
transgenic mice, since such a system enables ex-
tremely powerful yet flexible approaches to the study 
of genetically induced pathologies (for a review, see 
ref. 15). In fact, the first unequivocal demonstration 
that HFV can induce lesions in mammalian hosts was 
provided by our experiments with transgenic mice ex-
pressing various parts of the HFV genome. 13,16 
Mice expressing truncated amino terminal frag-
ments of gag and env (382 and 191 amino acids, 
respectively) and the intact bel region of HFV under 
transcriptional control of the homologous long termi-
nal repeat develop a rapidly progressive neurode-
generative disease and a myopathy with clinical 
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symptoms as early as 7 weeks after birth . In situ hy-
bridization experiments have shown that single neu-
rons in affected areas express very high levels of 
transgenic mRNA, while neighboring cells with iden-
tical morphological characteristics do not express 
detectable levels of the transgene. However, al-
though expression in adult mice is restricted to myo-
genic and central neuroepithelial tissues, a transient 
burst of expression occurs in several tissues during 
embryonic development without causing deleterious 
effects.1? These remarkably complex patterns of ex-
pression in HFV transgenic mice suggest that regu-
lation of HFV gene expression is controlled in vivo by 
an interplay of virally encoded genes and by host fac-
tors , some of which are likely to be expressed only in 
specific tissues. In particular, the irregular distribution 
of cells expressing the transgene within affected tis-
sues is rarely observed in transgenic mice and has 
led us to propose that bel-1 , a transactivating factor, 
may deregulate HFV transcription by triggering an au-
tocatalytic cascade of transactivation in single per-
missive cells and eventually lead to their degenera-
tion .1? 
In order to gain more insights into the regulation of 
HFV gene expression in vivo, we set out to determine 
which of the several reading frames encoded by HFV 
are translated into proteins in the diseased tissues of 
transgenic mice. To this end, we have cloned DNA 
fragments corresponding to parts of the structural 
and regulatory reading frames of HFV into bac-
terial expression vectors. We have then expres-
HFV genome 
HFV Af frame shift 
pol 
sed recombinant protein fragments as bacterial 
l3-galactosidase fusion proteins in an Escherichia coli 
expression system and used these recombinant pro-
teins to raise rabbit antisera. In the present work we 
show that such antisera react with the appropriate 
proteins in radioimmunoprecipitation experiments 
and recognize denatured epitopes in paraffin-
embedded tissues when used for immunohistochem-
ical stains. Taking advantage of these reagents, we 
have proceeded to describe the pattern of immunore-
activity in the brain of HFV transgenic mice shortly 
before and after onset of the neurodegenerative dis-
ease. 
Materials and Methods 
Construction of Prokaryotic Expression 
Plasmids 
HFV gene fragments corresponding to defined re-
gions of gag, pal, en v, and bel-1 were derived from 
the coding regions of pHSRV4 (as shown in Figure 
1) and molecularly cloned into the bacterial expres-
sion vector pROS.18 The correct in frame insertion 
of the fragments at the carboxy terminus of the 
l3-galactosidase coding sequence was verified by 
DNA sequencing of the molecular clones (A. Reth-
wilm, unpublished observations). Fusion proteins 
were purified from induced BMH 71 - 18 bacteria18 
by preparation of inclusion bodies and preparative 
-----
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Figure 1. Genomic sm,cture of HFV and position of the deletiollS introdllced in the pt.gpe Co/lSm/ct. The shaded boxes ill the lower part of the 
figure indicate the portiollS of HFV reading frames cloned into E. coli expression vectors. The bar indicates the cDNA fragment clolled into 
pGem4bel, an in vitro trallScription vector utilized to generate the n'bonucleic acid probes f or in situ hybridiz ation. AbbrevialiollSfor the gene prod-
ucts of HFV are: gag, group-specific antigen; pr, protease; rt, reverse transcriptase; in, integrase (elldonuclease); S1l, surface proteill; tm, trallSmem-
brane protein . Restriction sites are abbreviated as f ollows: A, Accl ; E, Eco Rl; H, HindIlI; Hp, Hp. l; M, Msp/; N, Nco l; P, PvuIl; 5, Sph/; St, Slu/; X, 
Xba /. 
sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SOS-PAGE) as described.19 Proteins used 
to immunize rabbits were more than 90% pure as 
deduced from Coomassie blue stained SOS-PAGE 
gels. 
Detection of Viral Proteins 
Metabolic labeling of HFV-infected baby hamster 
kidney cells (BHK-21) and radioimmunoprecipita-
tion (RIPA) were essentially performed as described 
recently.6 For detection of HFV proteins by Western 
blotting (WB), HFV-infected BHK-21 cells were 
lysed in detergent buffer [20 mM Tris-HCI , pH 7.4; 
0.3 M NaCI ; 1 % sodium deoxycholate; 1 % Triton 
X-100; 0.1 % SOS; 1 mM phenyl methyl sulfonyl fluo-
ride) , separated in SOS containing 10% polyacryl-
amide gels (SOS-PAGE) and blotted onto nitrocellu-
lose membranes (Schleicher & Schuell) . Strips were 
cut from the blotted membranes, blocked overnight 
in Tris-buffered saline [20 mM Tris-HCI, pH 7.6; 137 
mM NaCI) containing 5% bovine serum albumin 
(TBS/bovine serum albumin), washed in TBS con-
taining 0.5% Tween-20, and reacted with the first 
antibody. Antibody dilutions were 1 :50 in the case of 
the rabbit anti-pal serum and normal rabbit serum; 
1:100 for the human anti-HFV serum; and 1:500 for 
the rabbit anti-gag and bel-1 sera. Antisera were al-
lowed to react in TBS/bovine serum albumin for 30 
to 60 minutes. Strips were then washed again and 
reacted with peroxidase-conjugated secondary an-
tibody (Oako) for 60 min. After washing , the immu-
nostain was developed using a chemiluminescence 
detection system (Amersham). 
Purification of Recombinant HFV Proteins 
and Generation of Rabbit Antisera 
Lyophilized fusion proteins were reconstituted with 
water at a concentration of 1 mg/ml and emulsified 
with 3 volumes of complete or incomplete Freund's 
adjuvants (Gibco). New Zealand albino rabbits 
were primed with 4 ml of complete Freund's 
adjuvant/protein emulsion injected subcutaneously 
at multiple sites and boosted after 6 weeks with 4 
ml of incomplete Freund's adjuvant/protein emulsion 
intramuscularly. Blood (- 40 ml) was collected prior 
to the priming injection and 2 weeks after each 
boost. Serum was isolated by centrifugation after al-
lowing overnight clotting at 4 C. Immunoglobulins 
were partially purified by a two-step ammonium sul-
fate precipitation method.19 After dropwise addition 
of 0.5 volumes of a saturated ammonium sulfate so-
lution at 4 C, the precipitate was removed by cen-
Human Foamy Virus in Transgenic Mice 1063 
AJP Aprl11993, Vol . 142, No. 4 
trifugation. Additional ammonium sulfate solution 
was added to the decanted supernatant to a final 
50% saturation. Immunoglobulins were allowed to 
precipitate overnight at 4 C, collected by centrifu-
gation, resuspended in 5 ml of phosphate-buffered 
saline, and dialyzed against 3 x 2 liters of 
phosphate-buffered saline. Aliquots of antiserum 
were stored at -20 C after addition of 0.05% so-
dium azide. 
Processing of Mouse Tissues for 
Histological Analyses 
Transgenic and control mice were sacrificed by in-
tracardial perfusion with buffered formaldehyde (4% 
w/v) in deep anesthesia. Tissues were postfixed 
overnight in the same solution, transferred to 70% 
ethanol , and embedded in paraffin under RNAse-
free conditions in a VIP automatic infiltrator (Ames) 
through an ascending series of ethanols and three 
clearing baths of xylene. Samples were then 
vacuum-infiltrated with low-melting-point paraffin 
(Vogel) at 50 C overnight. Tissue sections of 3 ~m 
nominal thickness were cut, dried overnight on 
TESPA-treated slides20 at 56 C, deparaffinized in 
xylene, and either processed for in situ hybridiza-
tion, for immunohistochemistry, or stained with he-
matoxylin and eosin . Slides were finally dehydrated 
and mounted in a xylene-compatible medium (En-
tellan Neu, Merck). 
In Situ Hybridization 
The transcription vector pGem4bel, which contains 
a EcoRI-Hindlll fragment derived from the bel re-
gion of HFV, was used to prepare sense and anti-
sense complementary RNA probes by in vitro tran-
scription in the presence of 35S-rUTP. The resulting 
probe was previously shown to recognize all HFV 
transcripts identified thus far.17 Additional ribo-
probes were prepared from the pKSbel-1 vector. 
pKSbel-1 was derived by cloning a 1.1-kb Sspl 
fragment from the bel region into the Smal site of 
the pBluescript-KS+ in vitro transcription vector 
(Stratagene) and was shown to yield superimpos-
able results in in situ hybridizations (A. Aguzzi and 
A. Rethwilm, unpublished observations). The radio-
labeled transcripts were partially degraded by con-
trolled hydrolysis in 100 mM bicarbonate buffer (pH 
9.4, 65 C, 60 minutes) to an average length of 50-
100 bp and resuspended in 50% freshly deionized 
formamide. The extent of hydrolysis was monitored 
on a denaturing agarose gel (2% agarose, 10% for-
maldehyde). In situ hybridizations were performed 
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essentially as described.21 Our hybridization mix-
ture contained the radiolabeled probe at a concen-
tration of 200-300 x 103 dpm/j..J1 in 4X standard sa-
line citrate, 50% formamide, 10% dextrane sulfate, 
1 x Denhard 's solution , 100 ng/j..J1 transfer RNA, 1 
mM unlabeled S-rUTP, and short unrelated unla-
beled S-rUTP containing transcripts in approxi-
mately 10x molar excess of the probe. Sense-
transcribed RNA probes were used as negative 
controls. Posthybridization processing included 
RNAse A digestion (20 j..Jg/ml , 30 minutes at 37 C), 
and several low- and high-stringency washes over a 
period of 30 hours. Slides were then dried, dipped 
in NTB-2 nuclear track emulsion (Kodak), and ex-
posed at 4 C. The exposure times ranged between 
1 and 4 days. 
Immunohistochemical Methods 
Deparaffinized, rehydrated tissue sections of HFV 
transgenic and control mice were incubated with 
antisera 122, 123, 124, 125, 127, 161 , and 162 di-
luted in phosphate-buffered saline to the following 
strengths: 1 :20, 1: 1 00, 1 :500 (Table 1). Dilutions of 
1 :250 of antisera 161 and 162 were applied on se-
lected sections. Predigestion with various concen-
trations of pronase E (Sigma) did not improve the 
sensitivities of the immunostains. Detection was ac-
complished essentially as described22 using the 
avidin-biotin complex-peroxidase method and di-
aminobenzidine as a chromogenic substrate. Sec-
tions were either lightly counterstained with diluted 
hematoxylin or mounted without counterstaining . In-
spection and microphotography were carried out on 
a Zeiss Axiophot microscope equipped with differ-
ential interference contrast optics. 
Table 1. Synopsis of Antisera to HFV Gene Products 
and Their Immunohistochemical Properties 
Im-
Antiserum muno-
no. gen 
122 gag 1 
123 (t1 
124 tm1 
127 gag2 
161 be/-1 
162 be/-1 
Non-
Signal Signal specific 
Dilution pHFV AI p~gpe stain 
1:20 +++ +++ ++ 
1 :100 +++ +++ 
1:500 + + 
1:20 ++ 
1 :100 
1:500 
1:20 + ++ 
1:100 + 
1:500 
1:20 +++ ++ 
1:100 +++ + 
1:500 + 
1:20 +++ +++ ++ 
1:100 +++ +++ + 
1:500 + + 
1:20 +++ +++ ++ 
1:100 +++ +++ + 
1:500 + + 
Results 
Characterization of Viral Proteins by 
Rabbit Antisera 
Rabbit antisera were raised to various portions of 
the HFV reading frames, as detailed in Figure 1, 
and their specificity was tested by WB and by RIPA. 
The human serum containing antibodies to HFV6 
recognized viral proteins in the range of 27 to 74 kd 
in WB (Figure 2A, lane 1). 
116 kD 
97 kD 
66 kD 
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29 kD 
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Figure 2. Western blot (A) and radlolmmtllloprecipitatlon (8) with 
antisera to HFV. A, human positive senml c:z6 (lane 1); lIormal rab-
bit senlm (lane 2) ; allt/senlm ]22 allti gag1 (lane 3); aPlliserum ]27 
aPlli gag2 (lane 4); alltisentm ]23 allti n1 (lane 5); aPllisenJ1n ]6] 
allli bel-l (lane 6). 8 precipitatloll oJ the 130 kD env precursor mol-
ecule byalllisenml 124 (OIl1i tm). 
Viral proteins of 70 and 74 kD have been de-
scribed to be diagnostically useful in discriminating 
between foamy virus positive and negative sera.6 
Both the 70 and 74 kd proteins were recognized by 
our anti-gag antibodies generated against the 
amino terminus and the domain of the major capsid 
protein of HFY gag (Figure 2A, lanes 3 and 4). We 
therefore conclude that the 70/74 kd double band 
represents the gag precursor pr70/74g ag of HFY. 
Retroviral gag precursor proteins are cleaved by 
the viral protease into the amino terminal matrix pro-
tein (MA) , the major capsid protein (CA), and the 
carboxy terminal nucleocapsid protein (NC).23 
The detection of p27g ag and p32gag by the gag 
antisera 1 and 2 identifies these proteins as the MA 
and CA proteins, respectively. Both proteins are 
readily recognized by the human anti-HFY-positive 
serum (Figure 2A, lane 1). The human serum and 
the gag antisera recognize several viral proteins in 
the molecular weight range of 50 to 60 kd. These vi-
ral proteins are likely to represent intermediate 
cleavage products of the gag precursor, in analogy 
to the gag proteins of human immunodeficiency vi-
rus .24.25 
When the pol antiserum was applied in a WB as-
say, two proteins of 127 and 80 kd were identified 
(Figure 2A, lane 5). These represent the pol precur-
sor molecule (127 kd) from which the protease, re-
verse transcriptase (80 kd) , and the integrase of 
HFY are cleaved .26 
The bel-1 antiserum detected two proteins of ap-
proximately 60 and 35 kd in HFY-infected cells (Fig-
ure 2A, lane 6). Bel-1-related proteins displaying 
these molecular weights had been previously iden-
tified as representing the bel-1 transactivator pro-
teins and bet, a fusion protein of unknown func-
tion .27 Identical results were obtained with rabbit 
anti-bel-1 sera (data not shown). 
To demonstrate the reactivity of the env antibody 
we used the RIPA methodology (Figure 2B) be-
cause we were not able to stain the viral glycopro-
teins with env-specific serum or serum of infected 
humans and monkeys in WB (data not shown). Viral 
glycoproteins of 47,130, and 160 kd have been de-
scribed previously and were suggested to repre-
sent the transmembrane protein, the surface 
protein, and the env polyprotein precursor, respec-
tively.6 However, the former study was performed 
without the use of specific antisera raised against 
defined portions of the env polypeptide. Precipita-
tion of a 130 kd molecule by our envantiserum gen-
erated against the transmembrane portion of the 
env protein (Figure 2B) indicates that gp 130 repre-
sents the env precursor protein . The lack of precip-
itation of the mature 47 kd transmembrane protein 
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by the env antiserum is likely due to minute 
amounts of the cleaved env proteins in infected 
cells. 
Characterization of Antisera to HFV 
Proteins by Immunohistochemistry 
The salient features of the transgenic mouse fami-
lies analyzed in this report have been described in 
detail elsewhere.13.16 The pHFY At transgene en-
codes the entire HFY genome, but its ability to gen-
erate infectious retroviral particles is disabled by a 
frameshift mutation in the pol reading frame. Two 
additional large deletions in the gag-pol and env re-
gions were introduced in the p~gpe construct (Fig-
ure 1). Consequently, mice harboring the pHFY A t 
transgene are able to express all full-length genes 
of HFY, with the exception of the retroviral endonu-
clease (integrase), whereas p~gpe transgenic mice 
can express only truncated gag and env fragments 
of 382 and 191 amino acids, respectively, in addi-
tion to the genes contained in the bel region . Immu-
nohistochemical studies and in situ hybridizations 
were performed on tissues from 46 transgenic mice 
(founders and their heterozygous and homozygous 
offspring) originating from seven independently mi-
croinjected zygotes (three pHFY At and four p~gpe). 
Partially purified rabbit antisera were tested on sec-
tions of transgenic brain tissues known to yield a 
signal when hybridized to a HFY riboprobe (as a 
positive control) and to brain sections of nontrans-
genic C57BI/6 mice (as a negative control) . Various 
dilutions of the antisera were applied as summa-
rized in Table 1. 
While a positive signal was never detected in 
wild-type mouse tissues, abundant immunoreactive 
material for antisera 122 (gag 1), 161 , and 162 
(bel-1) was demonstrated on sections of p~gpe 
transgenic mice. The brain of pHFY At mice dis-
played additional immunoreactivity for antisera 127 
(gag2) and 124 Um 1). Optimal signal-to-noise ra-
tios were obtained with dilutions of the purified, 5X 
concentrated antisera ranging between 1: 1 00 and 
1 :500 (Table 1). In contrast, antiserum 123 raised 
against the reverse transcriptase never yielded a 
positive reaction on paraffin-embedded tissues, de-
spite its reactivity in RIPA. 
HFV Immunoreactive Material Localizes to 
Neurons and Glial Cells in the Brain of 
Transgenic Mice 
In all mice containing the p~gpe construct the main 
cell type with accumulation of HFY proteins was the 
1066 Aguzzi et al 
AJP April 1993, Vo!. 142, No. 4 
neurons in the CA3 sub layer of the hippocampus 
(Figure 3, A and B) and the pyramidal neurons of 
the cortex (Figure 3, C and D). No immunoreactivity 
was detected in the white matter of these animals. 
However, pHFV At mice displayed additional immu-
noreactivity in a fraction of subcortically situated 
glial cells in both forebrain and cerebellum. This ob-
servation parallels our data on the expression of 
HFV mRNA in these regions.13 Interestingly, immu-
noreactivity for gag, env, and bel-1 was not con-
fined to the perikaryon of neuronal cells , but ex-
tended into the axonal and dendritic processes of 
neurons (Figure 4, A and B). 
Multifocal , somewhat diffusely staining deposits 
of immunoreactive material were observed in the 
cortex and subcortex (Figure 4A). Since no such 
deposits were observed in the brain of nontrans-
genic littermates upon immunostain with antisera 
161 and 162 (data not shown), and no cortical im-
munostain was observed in the brain of transgenic 
mice when preimmune sera from rabbits 161 and 
162 were used, we conclude that the deposits de-
picted in Figure 4A reflect the expression, and pos-
sibly the extracellular release, of transgenic bel-1 
protein . 
In the brain of both pHFV At and pilgpe animals 
older than 6 weeks, glial fibrillary acidic protein 
(GFAP) immunostains demonstrated a marked 
cortical and subcortical astrogliosis that extended 
to areas devoid of neuronal degeneration. Typical 
reactive astrocytes with long delicate GFAP-positive 
processes represented the dominating cell type. 
Back-to-back figures suggestive of completed cell 
divisions were frequently detected among astro-
cytes. 
Comparison of HFV in in Situ 
Hybridization and Immunohistochemistry 
We have visualized transcription and translation of 
HFV genes by in situ hybridization and immunohis-
tochemistry on consecutive serial sections of the 
brain of pHFV At and pilgpe mice. Quantitation was 
CA1 
09 , 
Figure 3. Consecutive serial sections of the brain of a pAgpe tra1lsgenic mouse at the age of 5 weeks (A alld B, hippocampus; C alld D, parietal 
cortex). Arrowheads ma rk the 013-012 regioll in the hippocampus. Nettrological sympto/ns were not yet apparent at this stage. tbe micrographs Oil 
the left ( A and C) depict in situ hybridlzations with the pGem4bel RNA probe, whereas those Oil the right side ( B and D) show Immunohistochem-
ical stains with all/Iser"m 122 (gag!). tbe similarity ill distribution and number of cells contaillillg mRNA alld HFV protellls Indicates that these 
two methods detect positive cells ill HFV transgenic mice with comparable sensitivity. X 100. 
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Figure 4. Immunohistochemical stallls for bel-! with alllisenlln 161. A, low-power micrograph demollStraling focal retiCIIlar deposits of the bel- ! 
trallsactivator protein witblll the molecular layer of the cerebral cortex (open arrows). The patchy, somewhat diffuse pal/em of ImmllllOreaclivlty 
suggests tbat deposits ofbel-1 accumulate at synaptic junctiollS and/or are released in tbe extracellular space. X 50. B high-power micrograph dis-
p1ayillB bel-! immunoreactive material ill "ucleus, perikaryoll, and processes of corticallleuro ,lS. X630. Note the highly irregular distribution of 
immunoreactivity with strongly immunoreactive (arrowheads) a'ld negative neuro,lS (a rrows) in close spatial proximity. 
achieved by counting the total number and the 
number of positive pyramidal neurons in the hippo-
campus and in the parietal cortex with both detec-
tion methods. Neurons were regarded as positive 
for HFV mRNA if the number of silver grains situated 
on the perikaryon exceeded the background counts 
by a factor of 5 or more on emulsion-coated, hybrid-
ized slides. In immunohistochemical stains, only 
neurons displaying a strong signal (Figures 3 and 4) 
were considered to be positive for HFV proteins. 
Identification of HFV gene products with antisera to 
gag 1 and be/-1 in all mice, and additionally of gag2 
and tm 1 in pHFV Af mice, correlated closely with the 
number of cells containing HFV mRNA. In a typical 
series of hippocampal sections from a 5-week-old 
p~gpe transgenic mouse, 21 and 25 positive cells 
among 501 hippocampal pyramidal neurons were 
identified by in situ hybridization and gag 1 immuno-
histochemistry, respectively (Figure 3, A and 8). In 
the parietal cerebral cortex of the same animal , 58 
and 75 cells scored positively for HFV mRNA and 
gag 1 immunohistochemistry from a total of 704 neu-
rons (Figure 3, C and D). 
Multinucleated Giant Cells and Atypical 
Astrocytes in the Brain of pHFVAf 
Transgenic Mice 
Two additional cell types were found in the brains of 
clinically symptomatic pHFVAf transgenic mice, the 
first consisting of atypical , large multinucleated 
cells located most often in the hilar and parahippo-
cam pal regions (Figure 5A). These cells will hence-
forth be called multinucleated giant cells (MGC). 
The shape of these cells was round , and their diam-
eter was often in excess of 50 IJm. They contained 5 
to 10 nuclei embedded in an abundant cytoplasm. 
Nuclear morphology was similar to that of neighbor-
ing activated astrocytes: the multiple nuclei were 
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Figure 5. Multinucleated g iant cells in the brain of pHFV /if transgenic mice. A, micrograph of the hilar region of the hippocampus showing one 
mllltilll/c1eated al'ld two hizarrely shaped giant cells. H&E, X 200, B, gag 1 immllnostain of a multinucleated giant cell. C, in situ hybridization 
with the same probe as in Figure 3, showing transgenic HFV mRNA in the cytoplasm of MGC. D-F, immunostain f or glial fibrillary acidic protein 
of MGC (D) and of bizarre, mono-, and binuclealed cells ex 400). These lalter cells are essentially devoid of processes and may represelll precursors 
of MGC. Multiple nuclei are highlighted by arrows. 
substantially isomorphic and contained finely dis-
tributed , occasionally peripheral , and somewhat 
condensed chromatin, and were arranged in prox-
imity to the plasma membrane in a horseshoe-like 
fashion reminiscent of Langhans giant cells . Mitotic 
figures or dyskaryosis were never observed in these 
cells , suggesting that MGC originated through syn-
cytial fusion rather than endomitosis. In contrast to 
the widespread occurrence of the astrogliosis, MGC 
were strictly confined to the areas of telencephalon 
displaying histological lesions; they were not found 
in the brainstem or in the cerebellum. MGC were 
also not observed extracranially in mice showing 
expression of HFV in skeletal and smooth muscle. 
Immunostains of MGC with antisera to HFV re-
vealed that they contained gag, env, and bel-1 , 
whereas none of these gene products were detect-
able in the more typical, reactive astroglial compart-
ment. gag proteins tended to accumulate in the 
central part of the cytoplasm of MGC (Figure 58), 
whereas env and bel-1 were more homogeneously 
distributed. Cytoplasmic HFV mRNA was readily 
detectable by in situ hybridization analysis in MGC 
(Figure 5C). 
Immunostains for GFAP revealed strong immu-
noreactivity of MGC for this marker protein , implying 
that they derive from astrocytes. However, the GFAP 
immunostaining pattern was coarsely vacuolar and 
differed markedly from that of neigh boring reactive 
astrocytes (Figure 50). No immunoreactivity was 
detected in MGC by using antibodies to leukocyte 
common antigen/C045 or to synaptophysin (data 
not shown). 
We also identified atypical large cells devoid of 
processes in brain sections of the same pHFV A t 
transgenic mice, which stained strongly with the 
GFAP antiserum (Figure 5, E and F). The appear-
ance of such cells was often globular, but occasion-
ally very irregular shapes were encountered (Figure 
5E). The occurrence of intermediate, occasionally 
binucleated forms (Figure 5F) suggests that these 
may represent MGC precursors. Although the mor-
phological characteristics of such cells profoundly 
differed from those of neighboring reactive astro-
cytes and were more reminiscent of neoplastic as-
troglia, nuclear atypias and mitotic figures were 
never detected. 
Discussion 
The specificity of the antisera described in this 
manuscript has been verified in a RIPA assay and 
by comparing the results of immunohistochemical 
stains to those of in situ hybridization experiments. 
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Northern hybridization analyses of p~gpe trans-
genic mice had previously demonstrated the pres-
ence of two mRNA transcripts of 7.1 and 3.8 kb, 
and a prominent group of transcripts of 1.8-2.5 
kb.17 These transcript lengths are consistent with an 
unspliced genomic mRNA enabling translation of a 
truncated gag product, a spliced env transcript, 
and a family of shorter transcripts, presumably re-
sulting in expression of the bel genes, in analogy to 
the splicing pattern of replication-competent HFV.9 
Interestingly, all cells containing HFV mRNA were 
found to express structural gene products and bel-1 
simultaneously, and no evidence of differential gene 
expression during the course of the disease was 
detected. This may suggest that HFV, in contrast to 
human immunodeficiency virus (HIV) and human 
T-cell leukemia virus (HTLV-I), could lack a rev-like 
function controlling the splicing pattern during the 
retroviral life cycle (for a review, see ref. 28). 
HFV Proteins Are Detectable in Nerve Cell 
Processes 
The detection of uniform, strong immunoreactivity 
for env and gag in nerve cell processes over sev-
eral hundreds of microns indicates that transport of 
these proteins to the neuropil is very efficient. Par-
ticularly surprising is the finding that bel-1 immu-
noreactivity was also found to be localized predom-
inantly in the cytoplasm and in the processes of 
affected neurons rather than in their nuclei . Al-
though the details of bel-1 action are poorly under-
stood , its trans-activating functionS demands its 
presence in the nucleus. Indeed localization, of 
bel-1 is predominantly nuclear in transiently trans-
fected cultured cells ,29 but during the early phases 
of the retroviral life cycle bel-1 was identified in the 
cytoplasm of infected fibroblasts .27 Together with 
these data, our observations suggest that subcellu-
lar localization of bel-1 may undergo cell-cycle-
dependent shifts. Alternatively, extranuclear immu-
noreactivity to the bel-1 antiserum may be due to 
the formation of compound proteins that may be 
partially homologous to bel-1, such as bet, bes, and 
the putative 170kO env-bel-1 fusion protein. In fact, 
antisera 161 and 162, although raised to recombi-
nant bel-1, coprecipitated several additional pro-
teins of various molecular weights in a RIPA assay. 
The atypical cellular localization of bel-1 in trans-
genic mice may be related to the pathological pro-
cesses observed: the spotty pattern of HFV immu-
noreactivity and its localization in the neuropil 
suggest that bel-1 may influence neighboring neu-
rons in a cell-autonomous fashion. It was not possi-
ble to gather direct evidence for this possibility in 
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vivo, but the antisera described in the present work 
should help to clarify this issue in organotypic neu-
ronal cultures.3o 
The antiserum raised against the reverse tran-
scriptase domain of the prot and pol reading frames 
did not yield positive immunohistochemical reac-
tions, although this reagent was shown to contain 
specific antibodies in a RIPA assay. It is possible 
that the epitopes recognized by this serum are not 
paraffin-stable or, alternatively, the concentration of 
pol gene products in vivo may be too low for immu-
nohistochemical detection. 
Syncytiogenic Activity of HFV 
Induction of syncytia in infected cells is a property 
shared by disparate enveloped viruses including 
complex retroviruses (e.g., HIV, SIVmac, and HTLV-
I), paramyxoviruses (measles virus and respiratory 
syncytial virus), and visna virus. To date HIV is by 
far the best characterized fusogenic retrovirus , and 
a large body of information has been gathered on 
mechanisms and the biological significance of its 
syncytium-forming potential. In vitro induction of 
syncytia in lymphoid cell lines by HIV closely corre-
lates with the spreading of retroviral infection and its 
cytotoxic potential and has been shown to require 
the action of viral env-derived proteins.31 .32 Specifi-
cally, a conserved undecapeptide has been identi-
fied to be shared by HIV-1 and HIV-2, paramyxovi-
ruses, Visna, and several simian retroviruses.27 
While syncytiogenic activity of HFV proteins is made 
likely by their immunohistochemical detection in the 
cytoplasm of MGC, the demonstration of transgenic 
HFV mRNA within MGC argues that immunoreactiv-
ity results from endogenous synthesis of HFV pro-
teins in these cells rather than from neuronophagia 
of HFV-expressing cells or from uptake of extracel-
lular protein. 
By analogy to HIV and HTLV-I, the HFV env gene 
product is the most likely candidate responsible for 
this activity. This view is supported by the fact that 
MGC were only observed in mice transgenic for the 
pHFV AI construct, which is a full -length viral con-
struct allowing expression of the intact env gene, 
but not in Pdgpe transgenic mice. Furthermore, a 
potential fusogenic sequence has been mapped to 
the HFV transmembrane protein.2 
A critical role in HIV-mediated cell fusion is attrib-
uted to host proteins, the presence of which is re-
quired in addition to HIV-env. Domains have been 
identified within CD4,33.34 intercellular adhesion 
molecule 1,35 and LFA-1 36, the deletion of which 
abrogates the fusogenic potential. Although such 
host factors have not been identified in HFV-
induced fusion , our observations suggest that simi-
lar interactions may be important. Syncytia in HFV 
transgenic mice were invariably composed of glial 
cells expressing GFAP, whereas neuronal fusions 
were not observed, despite the much higher propor-
tion of neurons expressing HFV. Therefore, one 
could speculate that presumptive cellular partner 
molecules may be present in vivo only in astrocytes. 
It will be of interest to search for MGC in the brain of 
experimental animals infected with HFV, since in 
vitro studies have revealed that HFV preferentially 
replicates in cell lines of astroglial origin .4 
Although the prominent fusogenic properties of 
HFV in cultured cells have been recognized for a 
long time, and indeed foamy viruses have been re-
ferred to in the past as "syncytial viruses," 10.11 .37 
formation of MGC in vivo was not observed in in-
fected patients or experimental animals. Also, MGC 
were not observed in transgenic mice expressing 
genes of HIV38 and HTLV-1.39-41 Therefore, this fea-
ture makes HFV transgenic mice an attractive in 
vivo model system in which syncytiogenic activity of 
human retroviruses can be studied. 
MGC of monocytic origin are an important diag-
nostic hallmark of HIV-associated giant cell enceph-
alitis (GCE)42.43 Although at first glance our find-
ings bear striking similarities to the histopathology 
of GCE, the resemblance is rather superficial : MGC 
in GCE essentially originate from hematopoietic 
cells expressing the CD4 receptor. In contrast, the 
presence of GFAP and the absence of immunoreac-
tivity for leukocyte common antigen and synapto-
physin argue that HFV-associated MGC derive from 
the astrocytic lineage. 
The finding that antibodies inhibiting syncytia for-
mation are of prognostic significance in HIV-
seropositive children lends support to the hypothe-
sis that in vivo fusogenic activity may play an 
important role in HIV pathogenicity.44 In the case of 
HFV transgenic mice the relevance of MGC to the 
course of the disease is not yet clear, since we have 
observed neurodegenerative pathologies, also in 
the absence of MGC. However, mice expressing 
full-length structural genes harbor MGC in the brain 
lesions and have a markedly reduced life expect-
ancy as compared to pdgpe mice, which do not 
develop MGC.16 Therefore, while MGC are not a 
necessary factor in the pathogenesis of the de-
scribed neurodegenerative disease, the strong cor-
relation between MGC and particularly severe neu-
roglial damage suggests that they may contribute to 
the HFV-induced neurological disease. 
Possible Application in Research and 
Diagnostics 
The present study also shows that our antisera rec-
ognize epitopes that are not destroyed by formalde-
hyde fixation and paraffin embedding, and that the 
sensitivity of the immunohistochemical reaction us-
ing a partially purified immunoglobulin fraction is 
comparable to that of radioactive in situ hybridiza-
tion. These useful properties have enabled us to 
characterize the pathology developing in HFV trans-
genic mice more systematically and to advance 
pathogenetic hypotheses which can now be ap-
proached in further molecular and morphological 
studies. Even more importantly, the above-
mentioned characteristics of the antisera described 
here make them suitable reagents for archival and 
prospective studies on human material. In view of 
the lack of knowledge about variability of HFV in 
natura, it is conceivable that antisera to potentially 
conserved, functionally important domains of HFV 
proteins may prove more sensitive than in situ hy-
bridization with ribonucleic acid probes. For these 
reasons we believe that these reagents will provide 
histopathologists and virologists with a further use-
ful tool for evaluating the pathogenic potential of 
natural HFV infection in humans. 
Acknowledgments 
We are indebted to Norma Howells for maintaining 
the rabbit colony, to Manuela Kranz for technical as-
sistance, and to Friedemann Kiefer and Otmar 
Wiestler for discussions, suggestions, and critical 
reading of the manuscript. 
References 
1. Achong BG, Mansell PW, Epstein MA, Clifford P: An 
unusual virus in cultures from a human nasopharyn-
geal carcinoma. J Natl Cancer Inst 1971, 46:299--307 
2. FIOgel RM, Rethwilm A, Maurer B, Darai G: Nucleotide 
sequence analysis of the env gene and its flanking re-
gions of the human spumaretrovirus reveals two novel 
genes. EMBO J 1987, 6:2077- 2084 
3. Rethwilm A, Darai G, Rosen A, Maurer B, FIOgel RM: 
Molecular cloning of the genome of human spumaret-
rovirus. Gene 1987, 59:19--28 
4. Rethwilm A, Baunach G, Netzer KO, Maurer B, 
Borisch B, ter Meulen V: Infectious DNA of the human 
spumaretrovirus. Nucleic Acids Res 1990, 18:733--738 
5. Maurer B, Serfling E, ter Meulen V, Rethwilm A: Tran-
scription factor AP-1 modulates the activity of the hu-
man foamy virus long terminal repeat. J Viro11991 , 65: 
6353-6357 
Human Foamy Virus in Transgenic Mice 1071 
AJP April 1993, vot. 142, No. 4 
6. Netzer KO, Rethwilm A, Maurer B, ter Meulen V: Iden-
tification of the major immunogenic structural proteins 
of human foamy virus. J Gen Virol 1990, 71 :1237- 1241 
7. Rethwilm A, Mori K, Maurer B, ter Meulen V: Transact-
ing transcriptional activation of human spumaretrovi-
rus LTR in infected cells . Virology 1990, 175:568- 571 
8. Rethwilm A, Erlwein 0 , Baunach G, Maurer B, ter 
Meulen V: The transcriptional transactivator of human 
foamy virus maps to the bel 1 genomic region . Proc 
Natl Acad Sci USA 1991 , 88:941 - 945 
9. Muranyi W, FIOgel RM: Analysis of splicing patterns of 
human spumaretrovirus by polymerase chain reaction 
reveals complex RNA structures. J Viro11991 , 65:727-
735 
10. Loh PC, Matsuura F, Mizumoto C: Seroepidemiology 
of human syncytial virus : antibody prevalence in the 
Pacific. Intervirology 1980, 13:87- 90 
11. Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, 
Levin A: The prevalence of naturally occurring anti-
bodies to human syncytial virus in East African popu-
lations. J Gen Virol 1980, 47:399--406 
12. Mahnke C, Kashaiya P, Rbssler J, Bannert H, Levin A, 
Blattner WA, Dietrich M, Luande J, Lbchelt M, 
Friedman-Kien A, Komaroff AL, Loh PC, Westarp ME, 
FIOgel RM: Human spumavirus antibodies in sera from 
African patients. Arch Virol 1992, 123:243--253 
13. Aguzzi A, Bothe K, Wagner EF, Rethwilm A. Horak I: 
Human foamy virus : an underestimated neuropatho-
gen? Brain Pathol 1992, 2:61-69 
14. Werner J, Gelderblom HR: Isolation of foamy virus 
from patients with de Quervain thyroiditis. Lancet 
1979, 2:258--259 
15. Wagner EF: On transferring genes into stem cells and 
mice. EMBO J 1990,9:3025--3032 
16. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I: 
Progressive encephalopathy and myopathy in trans-
genic mice expressing human foamy virus genes. Sci-
ence 1991 , 253:555- 557 
17. Aguzzi A, Bothe K, Horak I, Rethwilm A. Anhauser I, 
Wagner EF: Developmental modulation of human 
foamy virus expression. New Bioi 1992, 4:225- 237 
18. Ellinger S, Glockshuber R, Jahn G, Pluckthun A: 
Cleavage of procaryotically expressed human immu-
nodeficiency virus fusion proteins by factor Xa and 
application in western blot (immunoblot) assays. J 
Clin Microbiol 1989, 27:971-976 
19. Harlow E, Lane 0: Antibodies. Cold Spring Harbor, 
NY, CSH Press, 1988. 
20. Henderson C: Aminoalkylsilane : an inexpensive, sim-
ple preparation for slide adhesion. J Histotechnol 
1990,12:123--124 
21 . Aguzzi A, Wagner EF, Williams RL, Courtneidge SA: 
Sympathetic hyperplasia and neuroblastomas in 
transgenic mice expressing polyoma middle T anti-
gen. New Biologist 1990, 2:533-543 
22. Aguzzi A, Kleihues P, Heckl K, Wiestler OD: Cell-type 
specific tumor induction by oncogenes in fetal fore-
brains transplants. Oncogene 1991, 6: 113--118 
